University of Texas/Texas AM Investment Management Co (UTIMCO)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
University of Texas/Texas AM Investment Management Co (UTIMCO)'s VRTX Position: Q2 2026 in Review
University of Texas/Texas AM Investment Management Co (UTIMCO) increased its Vertex Pharmaceuticals (VRTX) stake by 278% in Q2 2026, buying an estimated $117K and bringing the position to 359 shares worth $178K. The position accounts for 0.02% of the portfolio, ranked #168.
University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in VRTX in Q4 2023 and has held it in 7 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- University of Texas/Texas AM Investment Management Co (UTIMCO) held 359 shares of Vertex Pharmaceuticals worth $178K as of Q2 2026.
- University of Texas/Texas AM Investment Management Co (UTIMCO) bought 264 Vertex Pharmaceuticals shares in Q2 2026, an estimated $117K.
- Vertex Pharmaceuticals made up 0.02% of University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio in Q2 2026, its #168 holding.
- University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 7 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.